Association of major histocompatibility complex class II alleles with graves disease in Brazilian patients

Authors

  • Léa M.Z. Maciel Divisão de Endocrinologia. Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - FMRP/USP
  • Sandra S. Rodrigues
  • Ralph S. Dibbern Divisão de Endocrinologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - FMRP/USP
  • Paula A.A. Navarro Divisão de Endocrinologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - FMRP/USP
  • Eduardo A. Donadi Divisão de Imunologia Clínica. Departamento de Clínica Médica da Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo-FMRP/USP

DOI:

https://doi.org/10.11606/issn.2176-7262.v33i1p42-46

Keywords:

Grave’s Disease. Major Histocompatibility Complex. Association. Alleles.

Abstract

Graves’disease (GD) is the most frequent cause of hyperthyroidism. Although the etiology is not completely elucidated, there are several lines of evidence suggesting multifactorial mechanisms. Genetical, constitutional and environmental factors are involved in the pathogenesis. Major Histocompatibility Complex (MHC) Class II alleles have been associated with GD in several populations of distinct ethnic background and there is increasing evidence supporting an association between GD and HLA-DR3 in Caucasian populations. The MHC Classe II alleles were evaluated in our highly miscigenated population with GD and in control individuals of the same geographic area. MHC Class II genes were identified using PCR-amplified DNA hybridized with sequence-specific probes. HLA DRB1*0301 allele was significantly increased in patients (44,7%) as compared with controls (22,3%, pc=0.0068), conferring a Relative Risk (RR) of 4.1 and an Etiologic Fraction of 28.7. HLA-DQB1*0602 allele was significantly decreased in patients (pc=0.00062), conferring an RR and a Preventive Fraction of 1.8 and 26.7, respectively. Although the Brazilian population is highly miscegenated, the results corroborated the participation of the allele HLA-DRB1*0301 as a susceptibility marker to GD. In contrast, the protection conferred by the HLA-DQB1*0602 allele seems to be peculiar to Brazilian patients.

Downloads

Download data is not yet available.

Author Biographies

  • Léa M.Z. Maciel, Divisão de Endocrinologia. Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - FMRP/USP

     

    Docente da Divisão de Endocrinologia. Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - FMRP/USP

  • Sandra S. Rodrigues

    Técnica do Laboratório de Biologia Molecular

  • Ralph S. Dibbern, Divisão de Endocrinologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - FMRP/USP

    Monitor da Divisão de Endocrinologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - FMRP/USP

  • Paula A.A. Navarro, Divisão de Endocrinologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - FMRP/USP

    Monitora da Divisão de Endocrinologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - FMRP/USP

  • Eduardo A. Donadi, Divisão de Imunologia Clínica. Departamento de Clínica Médica da Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo-FMRP/USP

     

    Docente da Divisão de Imunologia Clínica. Departamento de Clínica Médica da Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo-FMRP/USP

Published

2000-03-30

Issue

Section

Simpósio: Associação do Sistema HLA com Doenças no Brasil

How to Cite

1.
Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA. Association of major histocompatibility complex class II alleles with graves’ disease in Brazilian patients. Medicina (Ribeirão Preto) [Internet]. 2000 Mar. 30 [cited 2024 May 21];33(1):42-6. Available from: https://revistas.usp.br/rmrp/article/view/7259